Active Surveillance Prostate Cancer Video Chat, March 25th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Novartis, Telix, Blue Earth Diagnostics, and Foundation Medicine.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
AnCan – Dan 8:17 PM
2nd Opinions for Biopsies -Jonathan Epstein, MD Contact: jepstein@imppllc.com https://advanceduropathology.com -Ming Zhou, MD, PHD Now at Mount Sinai Health System in New York City. If you have questions for him, please contact him directly at Email: Ming.zhou@mountsinai.org -John Hopkins Pathology https://pathology.jhu.edu/patient-care/second-opinions Biopsy Videos/Links topics: Master pathologist Zhou continues his primer on prostate biopsies https://howardwolinsky.substack.com/p/master-pathologist-zhou-continues Second Opinion Diagnosis in Prostate Pathology Grand Rounds in Urology https://www.youtube.com/watch?v=rTjOED_da1I Should You Get a Second Opinion on Gleason 6 Pathology Slides? Expert Laurence Klotz, MD https://www.youtube.com/watch?v=J9DE6xhKQ_4 Prostate Biopsy: The Beginning of the End? with Dr. Mark Emberton(3/2026) https://aspatients.org/meeting/prostate-mri-vs-biopsy-emberton/ Discusses Biopsy prostate trauma(seeding), MRI first, and many others
Dave G 8:41 PM
Dave Gursky dbgursky@gmail.com
BJ 8:45 PM
thanks guys see you next week
Dean (Denver) 8:45 PM
Dan, can you put that comment about PCRI video in chat
Dean (Denver) 8:58 PM
Never mind Dan, I got it
Dan Pertschuk-San Diego 9:15 PM
Dr. Scholz from PCRI talking about the clinical implication of the different prostate biopsy results. On You tube 2 days ago.
Andy Douglas 9:18 PM
file:///D:/Downloads/cancers-17-02193-v3.pdf
AnCan – Rick 9:18 PM
Dr. Epstein…. 516-760-2037
AnCan – Dan 9:19 PM
https://pmc.ncbi.nlm.nih.gov/articles/PMC12249354/
AnCan – Rick 9:26 PM
Greg Burns tonight on Solo Arts Heal 7.30 Pacific https//:themarsh.org/soloartsheal JOIN US!
AnCan – Rick 9:27 PM
Off to Solo Arts Heal!
Milton 9:30 PM
Gotta run. Thank you to everyone in the group!
European Prostate Cancer Virtual Support Group, March 18, 2026
Our European AnCan audience, who find it tough to attend meetings at late hours of the night, have requested a meeting at a more time-friendly hour. Unlike our other prostate groups, this meeting is open to all levels until there is a quorum to establish separate groups for different levels of prostate cancer. The meeting will start with the lowest grade, allowing men to drop out along the way.
This peer-led, free, and drop-in meeting is open to patients and care partners and will be conducted in English. It is open to all; however, Euro-based participants are given priority. This group is held on the 3rd Wednesday of each month at 2 pm Eastern/ 8 pm CET in The Barniskis Room (222-583-973) https://ancan.org/barniskis Sign up to receive a Reminder at https://ancan.org/contact-us
AnCan thanks the following sponsors for making this recording possible: Novartis, Telix, Blue Earth Diagnostics and Foundation Medicine.
Views expressed in this Recording are solely the opinion of AnCan Foundation, our Moderators and Participants.
AnCan does not accept sponsored promotion. Any drugs, protocols or devices discussed are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
All AnCan’s groups are free and drop-in … join us in person sometime! You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/ Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/
Join our other free and drop in groups:
Men (Only) Speaking Freely…1st & 3rd Thursdays @ 8.00 pm Eastern https://ancan.org/men-speaking-freely/
Veterans Healthcare Navigation… 1st & 3rd Tuesdays @ 8.00 pm Eastern Schmier Room https://ancan.org/veterans/
Veterans Speaking freely… 4th Tuesday @ @ 8.00 pm Eastern Schmier Room
Editor’s Pick: Is 5 years on enzalutamide without a change too long?
Topics Discussed
Recurrence well handled by a trial immunotherapy in Germany… or was it the radiation therapy; HT French style gives little wiggle room; surgery coming up fast at Martini to address advanced diagnosis; HT is working for Brit – BUT does it need changing up?; hyperbaric treatment in Eire to address RT cystitis
treatment options at the Nuclear Medicine in Heidelberg.
AnCan – Rick sent: 12:47 PM
Dr Jonathan Epstein. Advanced Uropathology of New York 700 Stewart Ave, Suite 101 Garden City, NY 11530 Hours: Monday-Friday 9:00AM – 6:00PM P: 516-760-2037 F: 516-200-3899 jepstein@imppllc.com
Active Surveillance Prostate Cancer Video Chat, March 11th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Novartis, Telix, Blue Earth Diagnostics, and Foundation Medicine.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.
Chat Log:
Michael 8:17 PM
I’m good, I have to drop off at five for work. Just got interrupted once so I may drop off before 5.
Eric- Atlanta 8:20 PM
TP with MRI Fusion list: https://www.researchgate.net/figure/List-of-some-current-platforms-for-MRI-ultrasound-fusion-biopsy_tbl3_379682364
Eric- Atlanta 8:23 PM
ExactVU finder: https://www.exactimaging.com/physician-finder
AnCan – Rick 8:30 PM
29 Neither DRE nor bicycle riding appreciably alters the PSA,30, 31 and most controlled studies evaluating ejaculation suggest it either does not significantly impact or modestly increases (~10%) PSA.32
AnCan – Rick 8:32 PM
(30) Crawford ED, Schutz MJ, Clejan S et al: The effect of digital rectal examination on prostate-specific antigen levels. JAMA 1992; 267: 2227 (31) Jiandani D, Randhawa A, Brown RE et al: The effect of bicycling on psa levels: A systematic review and meta-analysis. Prostate Cancer Prostatic Dis 2015; 18: 208 (32) Tarhan F, Demir K, Orcun A and Madenci OC: Effect of ejaculation on serum prostate-specific antigen concentration. Int Braz J Urol 2016; 42: 472
AnCan – Dan 8:34 PM
https://www.auanet.org/guidelines-and-quality/guidelines/oncology-guidelines/prostate-cancer
Eric- Atlanta 8:35 PM
Current NCCN Guidelines:https://www.nccn.org/patients/guidelines/content/PDF/prostate-early-patient.pdf
AnCan – Dan 8:40 PM
https://www.cancer.org/cancer/latest-news/can-getting-a-biopsy-make-cancer-spread.html
AnCan – Rick 8:41 PM
Cancer PEP https://cancerpep.com/
AnCan – Dan 8:43 PM
https://pmc.ncbi.nlm.nih.gov/articles/PMC10814235/
Eric- Atlanta 8:59 PM
Re NCCN: I could not find any NCCN preparation procedures for PSA test on their link from above.
AnCan – Rick 9:03 PM
the patient-centric guidelines that Eric posted are ‘dumbed down’ for our consumption. The actual guidelines are what dan gifford provided.
AnCan – Rick 9:13 PM
Should also point out that what Eric posted are NCCN. What we’re speaking about are the AUA Guidelines.
Dan Pertschuk-San Diego 9:23 PM
It’s said that we all live two lives and the second life begins when we realize we only have one.
Eric- Atlanta 9:33 PM
“Who is Eligible for PCPEP PC-PEP is being offered as part of a research study to men who have had a prostate cancer diagnosis and meet the following criteria: Are safe to exercise and do strength training Have access to email and internet daily Are able to watch videos and willing to follow the program for 6 months Have a life expectancy of 2 years or more Willing to take 4 on-line surveys over two years as part of the trial”
Marty Keough Auburn NY 9:36 PM
Sorry I could not get my camera to show me or audio to speak to you! Thanks for what You All Do! Marty Keough
AnCan’s ambitious CEO and Founder, Rick Davis, recently sat down with Rarity Life, the magazine published by Same But Different Creative, to share the deeply personal journey that led to the creation of AnCan.
In the interview, Rick reflects on his early days navigating a prostate cancer diagnosis — a moment that reshaped his life & his understanding of what true support should look like. Like so many survivors and thrivers, he quickly discovered that information alone isn’t enough. What people often need most is connection — the chance to speak openly with others who truly understand the lived experience of cancer.
That realization became the foundation of AnCan.
Rick shares how traditional support models don’t always meet people where they are. Geographic limitations, physical health challenges, financial strain, rare diagnoses, and even the emotional weight of walking into an in-person group can all create barriers. For many, simply showing up can feel overwhelming.
AnCan was built to remove as many of those barriers as possible.
Rick’s full interview in Rarity Life offers an inspiring look at leadership shaped by lived experience, and a reminder that meaningful change often begins with one person asking: How can we do this better?
